These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1623 related items for PubMed ID: 17905575

  • 21. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR, Schuermann W, Beckman O, Persson T, Polanowski T.
    Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176
    [Abstract] [Full Text] [Related]

  • 22. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A, Corradi M, Pigeon-Francisco C, Baronio R, Siergiejko Z, Petruzzelli S, Fabbri LM, Rabe KF.
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [Abstract] [Full Text] [Related]

  • 23. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
    Kew KM, Karner C, Mindus SM, Ferrara G.
    Cochrane Database Syst Rev; 2013 Dec 16; 2013(12):CD009019. PubMed ID: 24343671
    [Abstract] [Full Text] [Related]

  • 24. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE, Noonan MJ.
    J Asthma; 2010 May 16; 47(4):447-59. PubMed ID: 20528601
    [Abstract] [Full Text] [Related]

  • 25. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study.
    Lundborg M, Wille S, Bjermer L, Tilling B, Lundgren M, Telg G, Ekström T, Selroos O.
    Curr Med Res Opin; 2006 May 16; 22(5):809-21. PubMed ID: 16709303
    [Abstract] [Full Text] [Related]

  • 26. A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.
    Quirce S, Barcina C, Plaza V, Calvo E, Muñoz M, Ampudia R, Capel M.
    J Asthma; 2011 Oct 16; 48(8):839-47. PubMed ID: 21942354
    [Abstract] [Full Text] [Related]

  • 27. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
    Bisgaard H, Le Roux P, Bjåmer D, Dymek A, Vermeulen JH, Hultquist C.
    Chest; 2006 Dec 16; 130(6):1733-43. PubMed ID: 17166990
    [Abstract] [Full Text] [Related]

  • 28. Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting.
    Søes-Petersen U, Kava T, Dahle R, Lei Y, Dam N.
    Clin Respir J; 2011 Jul 16; 5(3):173-82. PubMed ID: 21679353
    [Abstract] [Full Text] [Related]

  • 29. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 16; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 30. Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?
    Aubier M, Haughney J, Selroos O, van Schayck OC, Ekström T, Ostinelli J, Buhl R.
    Ther Adv Respir Dis; 2011 Oct 16; 5(5):289-98. PubMed ID: 21586508
    [Abstract] [Full Text] [Related]

  • 31. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
    Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG.
    Lancet; 2006 Aug 26; 368(9537):744-53. PubMed ID: 16935685
    [Abstract] [Full Text] [Related]

  • 32. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark--cost-effectiveness analysis based on five randomised controlled trials.
    Wickstrøm J, Dam N, Malmberg I, Hansen BB, Lange P.
    Clin Respir J; 2009 Jul 26; 3(3):169-80. PubMed ID: 20298400
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
    Patel M, Pilcher J, Pritchard A, Perrin K, Travers J, Shaw D, Holt S, Harwood M, Black P, Weatherall M, Beasley R, SMART Study Group.
    Lancet Respir Med; 2013 Mar 26; 1(1):32-42. PubMed ID: 24321802
    [Abstract] [Full Text] [Related]

  • 34. Overall asthma control: the relationship between current control and future risk.
    Bateman ED, Reddel HK, Eriksson G, Peterson S, Ostlund O, Sears MR, Jenkins C, Humbert M, Buhl R, Harrison TW, Quirce S, O'Byrne PM.
    J Allergy Clin Immunol; 2010 Mar 26; 125(3):600-8, 608.e1-608.e6. PubMed ID: 20153029
    [Abstract] [Full Text] [Related]

  • 35. Combination therapy in asthma--fixed or variable dosing in different patients?
    Lötvall J.
    Curr Med Res Opin; 2004 Nov 26; 20(11):1711-27. PubMed ID: 15537472
    [Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy.
    Price D, Wirén A, Kuna P.
    Allergy; 2007 Oct 26; 62(10):1189-98. PubMed ID: 17845590
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
    Jenkins C, Kolarikova R, Kuna P, Caillaud D, Sanchis J, Popp W, Pettersson E.
    Respirology; 2006 May 26; 11(3):276-86. PubMed ID: 16635085
    [Abstract] [Full Text] [Related]

  • 38. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.
    O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekström T, Bateman ED.
    Am J Respir Crit Care Med; 2005 Jan 15; 171(2):129-36. PubMed ID: 15502112
    [Abstract] [Full Text] [Related]

  • 39. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K.
    Pulm Pharmacol Ther; 2014 Feb 15; 27(1):52-6. PubMed ID: 23583566
    [Abstract] [Full Text] [Related]

  • 40. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
    Bodzenta-Lukaszyk A, Buhl R, Balint B, Lomax M, Spooner K, Dissanayake S.
    J Asthma; 2012 Dec 15; 49(10):1060-70. PubMed ID: 23102189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 82.